Since updated 2025 consensus guidelines have changed treatment algorithms for CMV including refractory/resistant disease this content directly addresses gaps in these learners’ current clinical decision-making, making it immediately applicable to their existing scope of practice.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
No specific specialties targeted.
Address:
- 384 Inverness Parkway
Pricing
All courses included · from $18.75/mo
Courses are included in the subscription; some are also sold individually.
| Student Flex | $18.75/mo |
| Professional Flex | $60/mo |
| Student 3-Year | $100 |
| Student 2-Year | $112.50 |
+4 more plans
Collected from the provider’s public pages · source
Specialties served/covered
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Maternal-Fetal Medicine
- Medical Leadership & Administration
- Medical Oncology
- Mood & Anxiety Disorders
- Nephrology
- Neurocritical Care
- Neurodevelopmental Disabilities
- Neurology
- Neuroradiology
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Plastic & Reconstructive Surgery
- Practice Management & Ethics
- Pulmonary Disease
- Sleep Medicine
- Surgical Oncology
- Thoracic Anesthesia
- Urological Oncology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Conference / congress
- Credit · Up to 1 credit
- Commercial Support
-
ReleasedSep 30, 2026
-
Last day to claim creditOct 1, 2027 12 months left
-
Clinical Care Options, LLC (dba Decera Clinical Education) Treatment of Refractory/Resistant CMV in HCT Recipients: Optimizing Transplant Outcomes Through Contemporary CMV Management
-
Impact Education +1 Rethinking CMV Management Post-HSCT: What Would You Change?
-
AXIS Medical Education, Inc. Chairman’s Perspective: Reframing First-Line and Sequenced Care in Advanced Urothelial Carcinoma: Clinical Implications of the Updated NCCN Guidelines
-
Plexus Communications +1 Beyond BCMA: Exploring GPRC5D-Directed CAR T-Cell Therapies in Relapsed/Refractory Multiple Myeloma
-
Plexus Communications +1 Practice-Changing Insights and Implementation Strategies in LR-MDS
-
Plexus Communications +1 Navigating the Complexities of Treating Acute and Chronic Graft-vs-Host Disease With Targeted Agents
